Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management

Blanchard, Gabriela; Blanchard, Maël; Bernard, Pauline; Doms, Jacqueline; Cortes Sanchez, Begonia; Boulinguez, Serge; Guenova, Emmanuella

doi:10.1016/j.jdcr.2024.09.021

Scientific article

Case report

English

Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management

ContributorsBlanchard, Gabriela; Blanchard, Maël; Bernard, Pauline; Doms, Jacqueline; Cortes Sanchez, Begonia; Boulinguez, Serge; Guenova, Emmanuella

Published inJAAD case reports, vol. 54, p. 23-26

Publication date2024-12

First online date2024-10-12

Keywords

CCR4
CTCL
IBD
Sézary syndrome
Cutaneous T-cell lymphoma
Inflammatory bowel disease
Mogamulizumab
Mycosis fungoides

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Inflammation cutanée (919)

Funding

Swiss National Science Foundation - Systems medicine approach to tackle the problems of early diagnosing and prognostic stratification of mycosis fungoides [200253]

Citation (ISO format)

BLANCHARD, Gabriela et al. Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management. In: JAAD case reports, 2024, vol. 54, p. 23–26. doi: 10.1016/j.jdcr.2024.09.021

Article (Published version)

CC BY-4.0

Identifiers

PID : unige:183434
DOI : 10.1016/j.jdcr.2024.09.021
PMID : 39583058
PMCID : PMC11585813

Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S235251262400393X

Journal ISSN2352-5126

64views

94downloads

Creation22/01/2025 09:02:11

First validation25/02/2025 10:00:17

Update25/02/2025 10:00:17

Status update25/02/2025 10:00:17

Last indexation25/02/2025 10:00:18

Archive ouverte UNIGE

Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management

Technical informations